Goin Kathleen
An insider at 1 company in coverage, as reported on Form 4. SEC CIK 1912570. Latest Form 4 filed Oct 23, 2026.
Roles
As stated on the filings: the relationship to the company and any officer title.
| Company | Role | Transactions | First | Latest |
|---|---|---|---|---|
| Palvella Therapeutics, Inc.PVLA | Chief Operating Officer, Officer | 7 | 2026-10-21 | 2026-10-21 |
Transactions: 7
Every transaction reported, newest first, including grants, exercises and derivative securities. Purchases and sales (codes P and S) are open-market trades. The reported price is as stated on the form.
What these mean: insiders, Form 4, transaction codes, Rule 10b5-1 plans.
| Date | Company | Transaction | Shares | Reported price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Option exerciseStock Option (Right to Buy) | 2,148 | $0.00 | $0 | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Option exerciseStock Option (Right to Buy) | 2,165 | $0.00 | $0 | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Sale | 607 | $126.1949 | $76.6k | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Sale | 1,663 | $125.1645 | $208.1k | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Sale | 2,043 | $123.6214 | $252.6k | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Option exercise | 2,148 | $9.08 | $19.5k | Form 4 |
| 2026-10-21 | Palvella Therapeutics, Inc.Chief Operating Officer, Officer | Option exercise | 2,165 | $7.14 | $15.5k | Form 4 |
Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 1, 2026, 07:23 ET. Listed shows no prices and gives no investment advice.